Offer - Urjas Oil for just ₹ 1 X
Rheoran SF 50 Mcg/500 Mcg Rheocap is a prescription drug, available for use as Capsule. The alternative uses of Rheoran SF 50 Mcg/500 Mcg Rheocap have also been explained below.
The right dosage of Rheoran SF 50 Mcg/500 Mcg Rheocap depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Rheoran SF 50 Mcg/500 Mcg Rheocap also has some side effects, the most common being Shortness of Breath, Throat Irritation, Nosebleed. Apart from the aforementioned side effects, Rheoran SF 50 Mcg/500 Mcg Rheocap can also lead to other problems, which have been listed below. Usually, these side effects of Rheoran SF 50 Mcg/500 Mcg Rheocap go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Rheoran SF 50 Mcg/500 Mcg Rheocap has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Rheoran SF 50 Mcg/500 Mcg Rheocap's effects on the liver, heart and kidney are discussed below in the Rheoran SF 50 Mcg/500 Mcg Rheocap related warnings section.
The section on Rheoran SF 50 Mcg/500 Mcg Rheocap contraindications lists all such conditions.
Drug reaction of Rheoran SF 50 Mcg/500 Mcg Rheocap with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rheoran SF 50 Mcg/500 Mcg Rheocap is considered safe while driving, and is addictive.
Rheoran SF 50 Mcg/500 Mcg Rheocap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Rheoran SF 50 Mcg/500 Mcg Rheocap safe for pregnant women?
Pregnant women may experience moderate side effects from Rheoran SF. It is best to stop taking Rheoran SF immediately and inform your doctor if you notice any discomfort.
Is the use of Rheoran SF 50 Mcg/500 Mcg Rheocap safe during breastfeeding?
Rheoran SF may have very limited harmful effects for breastfeeding women.
What is the effect of Rheoran SF 50 Mcg/500 Mcg Rheocap on the Kidneys?
Rheoran SF is completely safe for kidneys.
What is the effect of Rheoran SF 50 Mcg/500 Mcg Rheocap on the Liver?
The liver can be affected by Rheoran SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rheoran SF only after medical advice.
What is the effect of Rheoran SF 50 Mcg/500 Mcg Rheocap on the Heart?
You may experience side effects on your heart after taking Rheoran SF. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rheoran SF 50 Mcg/500 Mcg Rheocap unless your doctor advises you to do so -
Is this Rheoran SF 50 Mcg/500 Mcg Rheocap habit forming or addictive?
Rheoran SF 50 Mcg/500 Mcg Rheocap does not cause addiction.
Interaction between Food and Rheoran SF 50 Mcg/500 Mcg Rheocap
Due to a lack of research, nothing can be said about the consequences of taking Rheoran SF 50 Mcg/500 Mcg Rheocap together with food.
Interaction between Alcohol and Rheoran SF 50 Mcg/500 Mcg Rheocap
No research has been done on this till date. Therefore, it is not known what the effect of taking Rheoran SF 50 Mcg/500 Mcg Rheocap with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359